TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis

L Larzabal1, A L de Aberasturi2, M Redrado1

  • 1Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.

British Journal of Cancer
|January 18, 2014
PubMed
Abstract

Insights

We discovered a new pathway where miR-205 links TMPRSS4 to integrin α5, inhibiting lung cancer cell invasion and metastasis. This finding offers new therapeutic targets for non-small cell lung cancer (NSCLC).

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • TMPRSS4 protease activity drives cell migration and invasion in lung cancer.
  • Elevated TMPRSS4 expression correlates with increased metastasis in non-small cell lung cancer (NSCLC).
  • The regulatory mechanisms of TMPRSS4 in lung cancer remain largely unknown.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying TMPRSS4's protumorigenic role in NSCLC.
  • To identify novel therapeutic targets for inhibiting lung cancer progression and metastasis.

Main Methods:

  • Microarray analysis identified miR-205 as upregulated upon TMPRSS4 inhibition.
  • Functional assays (migration, invasion, in vivo models) assessed miR-205's role.
  • Luciferase assays identified direct targets of miR-205 in NSCLC cells.

Main Results:

  • miR-205 overexpression induced an epithelial phenotype, cell cycle arrest, and inhibited growth and metastasis.
  • Integrin α5 was identified as a direct miR-205 target, crucial for cell migration and invasion.
  • TMPRSS4 silencing led to decreased integrin α5 levels, confirming the pathway.

Conclusions:

  • A novel molecular pathway involving TMPRSS4, miR-205, and integrin α5 in regulating NSCLC invasion and metastasis was elucidated.
  • This pathway represents a potential therapeutic target for novel anti-cancer strategies in NSCLC.

Related Concept Videos

Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
4.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K